SitemapContact UsHome
Emergent Technologies, Inc.





Our Portfolio Companies

Coradyn Biosystems, LLC
Smart polymer technology with potential applications in molecular sensor devices for a wide array of industries, including RFID or wireless sensing, medical devices and diagnostics, personal health monitoring, food and beverage testing, and industrial processing.
www.coradyn.com

Appian Labs, LLC
Biopharma company focused on designing delivery solutions tailored to pharmaceutical companies' drugs to improve their effectiveness; and to developing next-generation drug formulations for safer and improved health care.
www.appianlabs.com

MHC Biologics, LLC
Biotechnology company with a unique and proprietary portfolio of breakthrough technologies that can be used in the development and design of anti-cancer and infectious disease therapies for patients worldwide.
www.mhcbiologics.com

Reveal Sciences, LLC
is focused on color-changing indicators, biomolecular tests, and biomaterials for personal care and cosmetics applications.
www.revealsciences.com

AeonClad Coatings, LLC
is an advanced formulation company using pulsed plasma deposition technology to create highly specialized surface coatings for medical, industrial, and other applications.
www.aeonclad.com

Beacon Sciences, LLC
is a biopharmaceutical company focused on specialized binding assays using supra-molecular recognition and chemiluminescence.
www.beaconsciences.com

Mimetic Solutions, LLC
is a biopharmaceutical company specializing in smart-release polymers that are highly specific for triggered release of desired chemicals.
www.mimeticsolutions.com

Auxano Biomedical, LLC
is a biopharmaceutical company with a unique focus on wound healing - the reestablishment of tissues such as skin and the cornea.
www.auxanobio.com

Choncept, L.L.C.
is a biotech company focused on development of new technology to produce chondroitin from fermentation of recombinant bacteria to replace the current chondroitin source of beef and other animal by-products.
www.choncept.com

Heparinex, L.L.C.
is a biotech company focused on development of novel recombinant synthesis of compounds for the anticoagulation market to replace the current heparin source of beef and other animal byproducts.
www.heparinex.com

Hyalose, L.L.C.
has developed unique capabilities for the recombinant production of hyaluronic acid.
www.hyalose.com

Pure Protein, L.L.C.
has developed a unique method to produce soluble HLA protein from human cell lines for use in drug target discovery and bio-therapeutic development.
www.pureproteinllc.com

Pure Transplant Solutions, L.L.C.
A SUBSIDIARY OF PURE PROTEIN, L.L.C.
is using HLA protein to develop diagnostics, devices, and therapeutics which will eliminate rejection in organ transplants.

Pure Vaccine Solutions, L.L.C.
A SUBSIDIARY OF PURE PROTEIN, L.L.C
is using HLA protein to discover valuable new vaccine targets, improve existing vaccines, and design clinical trials for vaccine candidates.

Receptor Logic, Inc.
has developed an integrated diagnostic and therapeutic approach to be used in the design of customized anti-cancer and infectious disease treatments for individual patients.
www.receptorlogic.com

Selenium, Ltd.
is focused on the application of Selenium as an anti-bacterial agent and an anti-cellular, free radical chemistry technology.
www.seleniumltd.com